C
아이엠바이오로직스
493280KOSDAQ50.8 / 100
Reference Date: 2026-09-08
Financial Score16.5 / 40
News Sentiment21.3 / 25
Momentum3.0 / 20
Disclosure10.0 / 15
AI Analysis: the debt ratio is very low with excellent financial health but PER raises overvaluation concerns. Plunged 20.6% over the past month, and news sentiment is neutral.
Company InformationBased on 2025 Annual Report
Number of Employees
41people
Average Salary
76.2M KRW
Score Calculation Basis
Detailed Financial Score
PER
113.67Industry Average 15.000.0Point
7.6x industry avg (risky)
PBR
2.94Industry Average 1.200.0Point
2.5x industry avg (risky)
ROE
—Industry Average 8.003.5Point
Debt Ratio
1.09Industry Average 100.008.0Point
Half of industry avg (excellent)
Trend 5.0 / 10 points
Revenue Growth Rate
1.5 / 3
Operating Profit Growth Rate
1.5 / 3
ROE Trend
2.0 / 4
Detailed News Sentiment
2 totalPositive 2Neutral 0Negative 0Average Sentiment Score 85
- Positive'AI 의약 플랫폼' 미라보 바이오, 프리 A 40억원 투자 유치[마켓...
아이엠바이오로직스와 관련 없는 미라보 바이오의 AI 기반 항체 개발 플랫폼 투자 유치 소식으로 인해 간접적으로 긍정적 영향 예상.
- Positive아이엠바이오로직스 ‘IMB-201’ 67억 규모 국책과제 선정
아이엠바이오로직스의 항체 후보물질이 국가 주도의 대규모 기술개발 프로젝트에 선정되어 기업 가치 상승 기대.
Detailed Momentum
52-week position1.0Point
Near 52w low (0%, downtrend)
Current 14,550Won52-week high 104,00052-week low 13,800
1-month return0.0Point
1m -20.58% (strong drop)
Volume trend2.0Point
Volume decreasing
Detailed Disclosure
1 totalPositive 0Neutral 1Negative 0
- Neutral반기보고서 (2026.06)2026-08-12